{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:20Z","timestamp":1787162720574,"version":"build-2736575974"},"reference-count":70,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Bob and Nancy Edwards Scholarship","award":["SC1217"],"award-info":[{"award-number":["SC1217"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Med Decis Making"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Noninvasive prenatal testing (NIPT) was developed to improve the accuracy of prenatal screening to detect chromosomal abnormalities. Published economic analyses have yielded different incremental cost-effective ratios (ICERs), leading to conclusions of NIPT being dominant, cost-effective, and cost-ineffective. These analyses have used different model structures, and the extent to which these structural variations have contributed to differences in ICERs is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess the impact of different model structures on the cost-effectiveness of NIPT for the detection of trisomy 21 (T21; Down syndrome).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review identified economic models comparing NIPT to conventional screening. The key variations in identified model structures were the number of health states and modeling approach. New models with different structures were developed in TreeAge and populated with consistent parameters to enable a comparison of the impact of selected structural variations on results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The review identified 34 economic models. Based on these findings, demonstration models were developed: 1) a decision tree with 3 health states, 2) a decision tree with 5 health states, 3) a microsimulation with 3 health states, and 4) a microsimulation with 5 health states. The base-case ICER from each model was 1) USD$34,474 (2023)\/quality-adjusted life-year (QALY), 2) USD$14,990 (2023)\/QALY, (3) USD$54,983 (2023)\/QALY, and (4) NIPT was dominated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Model-structuring choices can have a large impact on the ICER and conclusions regarding cost-effectiveness, which may inadvertently affect policy decisions to support or not support funding for NIPT. The use of reference models could improve international consistency in health policy decision making for prenatal screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>NIPT is a clinical area in which a variety of modeling approaches have been published, with wide variation in reported cost-effectiveness.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>This study shows that when broader contextual factors are held constant, varying the model structure yields results that range from NIPT being less effective and more expensive than conventional screening (i.e., NIPT was dominated) through to NIPT being more effective and more expensive than conventional screening with an ICER of USD$54,983 (2023)\/QALY.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Model-structuring choices may inadvertently affect policy decisions to support or not support funding of NIPT. Reference models could improve international consistency in health policy decision making for prenatal screening.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1177\/0272989x241263368","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T05:34:36Z","timestamp":1722576876000},"page":"811-827","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing"],"prefix":"10.1177","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-5918","authenticated-orcid":false,"given":"Amber","family":"Salisbury","sequence":"first","affiliation":[{"name":"Menzies Centre for Health Policy and Economics, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia"},{"name":"The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Pearce","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"},{"name":"Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Howard","sequence":"additional","affiliation":[{"name":"Menzies Centre for Health Policy and Economics, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Norris","sequence":"additional","affiliation":[{"name":"Menzies Centre for Health Policy and Economics, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"International Network of Agencies for Health Technology Assessment. 2023. Available from: https:\/\/www.inahta.org\/"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0256-0"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X11409240"},{"key":"e_1_3_3_5_2","unstructured":"Medical Services Advisory Committee. Guidelines for preparing assessments for the Medical Services Advisory Committee. 2021. Available from: http:\/\/msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/MSAC-Guidelines"},{"key":"e_1_3_3_6_2","unstructured":"National Institute for Health and Care Excellence. Single technology appraisal: user guide for company evidence submission template. 2015. Available from: https:\/\/www.nice.org.uk\/process\/pmg24\/resources\/single-technology-appraisal-and-highly-specialised-technologies-evaluation-user-guide-for-company-evidence-submission-template-pdf-72286715419333"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15622643"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0106-x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211065479"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182368a0e"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407349"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13155"},{"issue":"4","key":"e_1_3_3_13_2","volume":"19","author":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment","year":"2019","unstructured":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment. Ont Health Technol Assess Ser. 2019;19(4):1\u2013166.","journal-title":"Ont Health Technol Assess Ser"},{"key":"e_1_3_3_14_2","volume-title":"The Non-Invasive Prenatal Test (NIPT) for Trisomy 21\u2014Health Economic Aspects","author":"Hulstaert F","year":"2014","unstructured":"Hulstaert F, Neyt M, Gyselaers W. The Non-Invasive Prenatal Test (NIPT) for Trisomy 21\u2014Health Economic Aspects. KCE Reports 222. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE); 2014."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01082-x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Husereau D Drummond M Augustovski F et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. MDM Policy & Practice. 2022;7(1). doi:10.1177\/23814683211061097","DOI":"10.1177\/23814683211061097"},{"key":"e_1_3_3_17_2","unstructured":"Medical Services Advisory Committee. Public summary document. Application No. 1492 \u2013 non-invasive prenatal testing (NIPT) for trisomies 21 18 and 13. 2019. Available from: http:\/\/www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/B1BCB2807D09C12DCA258258000F2025\/$File\/1492%20Final%20PSD.pdf"},{"key":"e_1_3_3_18_2","unstructured":"Organisation for Economic Co-operation and Development. Purchasing power parities (PPP) (indicator). 2023. Available from: https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. [Accessed 4 August 2023]."},{"key":"e_1_3_3_19_2","unstructured":"AIHW. Health Expenditure Database. 2023. Available from: https:\/\/www.aihw.gov.au\/about-our-data\/our-data-collections\/health-and-welfare-expenditure-database"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14791"},{"key":"e_1_3_3_21_2","unstructured":"The Royal Hospital for Women. Genetic Counselling: Reproductive Genetic Carrier Screening and Aneupolidy Screening (Including the Non-Invasive Prenatal Screening (NIPS Test). 2024. Available from: https:\/\/www.seslhd.health.nsw.gov.au\/stes\/default\/files\/documents\/geneticcounselling19.pdf"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4808"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Ayres AC Whitty JA Ellwood DA. A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a down syndrome screening program. Australian & New Zealand J Obstet & Gynaecol. 2014;54(5):412-417. doi:10.1111\/ajo.12223","DOI":"10.1111\/ajo.12223"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2016.1247800"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4157"},{"key":"e_1_3_3_26_2","unstructured":"Institute of Health Economics. First and second trimester prenatal screening update. 2014. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493544\/"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4311"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12612"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.09.025"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12136"},{"key":"e_1_3_3_31_2","first-page":"2905","article-title":"First trimester contingent screening for trisomies 21, 18, 13: is this model cost efficient and feasible in public health system?","volume":"30","author":"Colosi E","year":"2017","unstructured":"Colosi E, D'ambrosio V, Periti E. First trimester contingent screening for trisomies 21, 18, 13: is this model cost efficient and feasible in public health system? The Journal of Maternal-Fetal & Neonatal Medicine 2017;30:2905\u20132910. doi:10.1080\/14767058.2016.1268593","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03394-w"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.05.015"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/20479700.2020.1758893"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-019-0173-8"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.08.028"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000491750"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093559"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046582"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4699-4"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462319000308"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1038703"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132313"},{"key":"e_1_3_3_44_2","article-title":"Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies","volume":"15","author":"Garfield SS","year":"2012","unstructured":"Garfield SS, Armstrong SO. Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies. J Manag Care Med. 2012;15:32\u20139.","journal-title":"J Manag Care Med"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4704"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005922"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5605"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.770464"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001029"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4511"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131402"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2019.12.007"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225281"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-2-201107190-00002"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454577"},{"key":"e_1_3_3_56_2","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond M.","year":"2015","unstructured":"Drummond M. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford (UK): Oxford University Press; 2015.","edition":"4"},{"key":"e_1_3_3_57_2","unstructured":"Cleemput I Neyt M Thiry N De Laet C Leys M. Threshold values for cost-effectiveness in health care Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE); 2008. KCE reports 100C (D\/2008\/10.273\/96). Available from: https:\/\/kce.fgov.be\/sites\/default\/files\/2021-12\/d20081027396.pdf"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2022.1053719"},{"key":"e_1_3_3_59_2","unstructured":"National Council on Disability ed. Quality-adjusted life years and the devaluation of life with a disability. 2019. Available from: https:\/\/www.ncd.gov\/report\/quality-adjusted-life-years-and-the-devaluation-of-life-with-a-disability\/?fbclid=IwAR1AfU4IuDFEUJzzb-Ss41DwtsgBaURteroUwlpJ30-2sauRk3MEKBH6cok:National Council on Disability"},{"key":"e_1_3_3_60_2","unstructured":"Austrialian Institute of Health and Welfare. Australia\u2019s mothers and babies. Web report 2021. Available from: https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/australias-mothers-babies\/contents\/about"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.11.013"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.12.013"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00510-6"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12458160"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.01.004"},{"key":"e_1_3_3_66_2","volume-title":"2014 International Papillomavirus Conference","author":"Pillsbury M","unstructured":"Pillsbury M, Weiss T, Dasbach EJ. WebModel: web-based HPV dynamic transmission modeling. In: 2014 International Papillomavirus Conference, Seattle, WA, August 20\u201325, 2014."},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13505910"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9876.2011.01014.x"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X21990391"},{"key":"e_1_3_3_70_2","article-title":"Towards a reference case for use in future economic evaluations of interventions in osteoarthritis","volume":"68","author":"Drummond M","year":"2003","unstructured":"Drummond M, Maetzel A, Gabriel S, March L. Towards a reference case for use in future economic evaluations of interventions in osteoarthritis. J Rheumatol Suppl. 2003;68:26\u201330.","journal-title":"J Rheumatol Suppl"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4744-x"}],"container-title":["Medical Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X241263368","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0272989X241263368","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X241263368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:02:56Z","timestamp":1777658576000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0272989X241263368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1177\/0272989X241263368"],"URL":"https:\/\/doi.org\/10.1177\/0272989x241263368","relation":{},"ISSN":["0272-989X","1552-681X"],"issn-type":[{"value":"0272-989X","type":"print"},{"value":"1552-681X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}